Research programme: KD08 phosphate synthase inhibitors - Merck
Alternative Names: KD08 phosphate synthase inhibitors research programme - MerckLatest Information Update: 08 Feb 2017
At a glance
- Originator Cubist Pharmaceuticals
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 20 Sep 2004 No development reported - Preclinical for Gram-negative infections in USA (unspecified route)
- 16 Nov 2001 Preclinical development for Gram-negative infections in USA (Unknown route)